Risk of AIDS-defining cancers among HIV-1-infected patients in france between 1992 and 2009: Results from the FHDH-ANRS CO4 cohort

Clinical Infectious Diseases

Volumn 57, Issue 11, 2013, Pages 1638-1647

  Hleyhel, Mira ^a,b   Belot, Aurélien ^c,d,e   Bouvier, Anne Marie ^f   Tattevin, Pierre ^g   Pacanowski, Jérôme ^h   Genet, Philippe ⁱ   De Castro, Nathalie ^j   Berger, Jean Luc ^k   Dupont, Caroline ^l   Lavolé, Armelle ^m   Pradier, Christian ⁿ   Salmon, Dominique ^o,p   Simon, Anne ^q   Martinez, Valérie ^r   Costagliola, Dominique ^l,q   Grabar, Sophie ^a,p,s  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d INSTITUT DE VEILLE SANITAIRE   (France)

^e LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^f Institut Médical de Génétique et d Immunologie   (France)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^h HÔPITAL SAINT ANTOINE   (France)

ⁱ CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^j SAINT LOUIS HOSPITAL   (France)

^k REIMS UNIVERSITY HOSPITAL   (France)

^l HÔPITAL AMBROISE PARÉ   (France)

^m HÔPITAL TENON   (France)

ⁿ CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^o Service de Médecine Interne   (France)

^p UNIVERSITÉ PARIS DESCARTES   (France)

^q PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^r HÔPITAL ANTOINE BÉCLÈRE   (France)

^s NONE   (France)

more..

Author keywords

Aging; Cancer; HIV; Restored immunity; Risk

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; FRANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; STANDARDIZED INCIDENCE RATIO; UTERINE CERVIX CANCER; VIRUS LOAD;

AGING; CANCER; HIV; RESTORED IMMUNITY; RISK;

ADULT; AGE FACTORS; ANTI-RETROVIRAL AGENTS; FEMALE; FRANCE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 84887946197     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit497     Document Type: Article

References (31)

1. Schneider E, Whitmore S, Glynn K.M., et al Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years-United States, 2008. MMWR Recomm Rep 2008; 57: 1-12.
2. Clifford GM, Polesel J, Rickenbach M., et al Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97: 425-32.
3. Guiguet M, Boue F, Cadranel J., Lang JM, Rosenthal E, Costagliola D. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009; 10: 1152-9.
4. Silverberg MJ, Chao C, Leyden W.A., et al HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 2011; 20: 2551-9.
5. Frisch M, Biggar RJ, Engels E.A., Goedert JJ, Group AI-CMRS. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285: 1736-45.
6. Schulz TF. Cancer and viral infections in immunocompromised individuals. Int J Cancer 2009; 125: 1755-63.
7. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 59-67.
8. Grabar S, Abraham B, Mahamat A., Del Giudice P, Rosenthal E, Costagliola D. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement. J Clin Oncol 2006; 24: 3408-14.
9. Biggar RJ, Chaturvedi AK, Goedert J.J., Engels EA AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 2007; 99: 962-72.
10. Polesel J, Clifford GM, Rickenbach M, et al Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS 2008; 22: 301-6.
11. Polesel J, Franceschi S, Suligoi B., et al Cancer incidence in people with AIDS in Italy. Int J Cancer 2010; 127: 1437-45.
12. Patel P, Hanson DL, Sullivan P.S., et al Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148: 728-36.
13. Franceschi S, Lise M, Clifford G.M., et al Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010; 103: 416-22.
14. Franceschi S, Maso LD, Rickenbach M, et al Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer 2008; 99: 800-4.
15. Engels EA, Pfeiffer RM, Goedert J.J., et al Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20: 1645-54.
16. Engels EA, Biggar RJ, Hall H.I., et al Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008; 123: 187-94.
17. Shiels MS, Pfeiffer RM, Gail M.H., et al Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011; 103: 753-62.
18. Brock MV, Hooker CM, Engels E.A., et al Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr 2006; 43: 47-55.
19. Puoti M, Bruno R, Soriano V., et al Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004; 18: 2285-93.
20. Shiels MS, Pfeiffer RM, Engels EA Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 2010; 153: 452-60.
21. Supervie V, Costagliola D. The spectrum of engagement in HIV care in France: strengths and gaps. In: 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 2013. Abstract 1030.
22. Spaccaferri G, Cazein F, Lièvre L, et al Estimation de l'exhaustivité de la surveillance des cas de sida par la méthode capture-recapture, France, 2004-2006. Bull épidémiol Hebd 2010; 313-5.
23. Lewden C, Bouteloup V, De Wit S, et al All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol 2012; 41: 433-45.
24. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1998.
25. Breslow N, Day N. Statistical methods in cancer research. Lyon: IARC Scientific Publications, 1987.
26. Brown GW, Mood AM On median tests for linear hypotheses. Proc Second Berkeley Symp Math Statist Prob 1951; 159-66.
27. Chaturvedi AK, Mbulaiteye SM, Engels EA Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers. Ann Epidemiol 2008; 18: 230-4.
28. Lanoy E, Spano JP, Bonnet F, et al The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study. Int J Cancer 2011; 129: 467-75.
29. Besson C, Goubar A, Gabarre J., et al Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001; 98: 2339-44.
30. Spano JP, Costagliola D, Katlama C., Mounier N, Oksenhendler E, Khayat D. AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol 2008; 26: 4834-42.
31. Dal Maso L., Polesel J, Serraino D., et al Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009; 100: 840-7.